<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="4-part\PMC7255596\results\search\disease\results.xml">
  <result pre="(CZS) [2], Guillain-Barré syndrome (GBS) [3], and rare cases of" exact="encephalopathy" post="[4], meningoencephalitis [5], myelitis [6], uveitis [7], and severe"/>
  <result pre="Guillain-Barré syndrome (GBS) [3], and rare cases of encephalopathy [4]," exact="meningoencephalitis" post="[5], myelitis [6], uveitis [7], and severe thrombocytopenia [8]."/>
  <result pre="(GBS) [3], and rare cases of encephalopathy [4], meningoencephalitis [5]," exact="myelitis" post="[6], uveitis [7], and severe thrombocytopenia [8]. ZIKV is"/>
  <result pre="and rare cases of encephalopathy [4], meningoencephalitis [5], myelitis [6]," exact="uveitis" post="[7], and severe thrombocytopenia [8]. ZIKV is mainly transmitted"/>
  <result pre="encephalopathy [4], meningoencephalitis [5], myelitis [6], uveitis [7], and severe" exact="thrombocytopenia" post="[8]. ZIKV is mainly transmitted through the bite of"/>
  <result pre="responsible also for limiting the severity of illness caused by" exact="influenza" post="[59]. This suggests that the CD4+ T cell response"/>
  <result pre="cytokine-secreting and T cell-activating capacities of pDCs. In addition, during" exact="influenza" post="infection pDCs are capable of priming primary and secondary"/>
  <result pre="between the more recent DENV epidemics in Brazil and the" exact="microcephaly" post="epidemic observed after the introduction of ZIKV was in"/>
  <result pre="10.1056/NEJMc1602964 .26958738 6MecharlesS, HerrmannC, PoullainP, TranTH, DeschampsN, MathonG, et al.Acute" exact="myelitis" post="due to Zika virus infection. Lancet. 2016;387(10026):148110.1016/S0140-6736(16)00644-9 .26946926 7FurtadoJM,"/>
  <result pre="burden of disease caused by co-circulation and co-infection of dengue," exact="chikungunya" post="and Zika in the Americas. Travel medicine and infectious"/>
  <result pre="dengue, chikungunya and Zika in the Americas. Travel medicine and" exact="infectious disease." post="2016;14(3):177–9. Epub 2016/05/26. 10.1016/j.tmaid.2016.05.004 .27224471 16LesslerJ, ChaissonLH, KucirkaLM, BiQ,"/>
  <result pre="that maternal dengue antibodies are important in the development of" exact="dengue hemorrhagic fever" post="in infants. The American journal of tropical medicine and"/>
  <result pre="et al.Original antigenic sin and apoptosis in the pathogenesis of" exact="dengue hemorrhagic fever." post="Nature medicine. 2003;9(7):921–7. Epub 2003/06/17. 10.1038/nm887 .12808447 26PantojaP, Perez-GuzmanEX,"/>
  <result pre="al.Preexisting influenza-specific CD4+ T cells correlate with disease protection against" exact="influenza" post="challenge in humans. Nature medicine. 2012;18(2):274–80. Epub 2012/01/31. 10.1038/nm.2612"/>
  <result pre="al.Cytokine-dependent induction of CD4+ T cells with cytotoxic potential during" exact="influenza" post="virus infection. Journal of virology. 2013;87(21):11884–93. Epub 2013/08/30. 10.1128/JVI.01461-13"/>
  <result pre="10.3390/microorganisms8010056 .31905661 75CarvalhoMS, FreitasLP, CruzOG, BrasilP, BastosLS. Association of past" exact="dengue fever" post="epidemics with the risk of Zika microcephaly at the"/>
  <result pre="of past dengue fever epidemics with the risk of Zika" exact="microcephaly" post="at the population level in Brazil. Sci Rep. 2020;10(1):1752"/>
  <result pre="77RobbianiDF, OlsenPC, CostaF, WangQ, OliveiraTY, NeryNJr., et al.Risk of Zika" exact="microcephaly" post="correlates with features of maternal antibodies. J Exp Med."/>
 </snippets>
</snippetsTree>
